Hims & Hers Prices Upsized $350M Convertible Notes at 32.5% Premium for Growth
HIMS sits 61% above its 52-week low of $13.74.
Summary
Hims & Hers Health, Inc. priced an upsized $350 million offering of 0.00% Convertible Senior Notes due 2032, with an initial conversion price representing a 32.5% premium over its recent stock price. The proceeds will fund international expansion, including the Eucalyptus acquisition, and AI-driven platform investments.
Key Events · Financing and Capital Events · HIMS
-
Upsized Convertible Senior Notes Offering Priced
Hims & Hers priced an upsized private offering of $350 million aggregate principal amount of 0.00% Convertible Senior Notes due 2032. Initial purchasers have an option to buy an additional $52.5 million.
-
Favorable Pricing Terms
The notes bear 0.00% interest and have an initial conversion price of approximately $29.53 per share, representing a 32.5% premium over the last reported stock price of $22.29 on May 18, 2026.
-
Strategic Use of Proceeds
Net proceeds of approximately $338.5 million (or $389.5 million if the option is fully exercised) will be used to fund international expansion, including the Eucalyptus acquisition, and to invest in technology, fulfillment infrastructure, and AI capabilities.
-
Dilution Mitigation Measures
The company entered into capped call transactions, with an initial cap price of approximately $50.15 per share (125% premium), to reduce potential dilution upon conversion of the notes.
Analysis · HIMS · Industrial Applications And Services
Hims & Hers Health, Inc. has secured significant capital through an upsized convertible notes offering. The favorable terms, including 0.00% interest and a substantial 32.5% conversion premium, indicate strong institutional demand and confidence in the company's future. This financing provides crucial flexibility to execute on its international expansion strategy, including the previously announced Eucalyptus acquisition, and to accelerate investments in AI and technology, which are key drivers for future growth, especially following a Q1 net loss.
At the time of this filing, HIMS was trading at $22.16 on NYSE in the Industrial Applications And Services sector, with a market capitalization of approximately $5.1B. The 52-week trading range was $13.74 to $70.43. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.